Optellum at AI@Oxford Conference

Optellum Founder and Chief Science & Technology Officer will share the lessons learned by Optellum in enabling early lung cancer diagnosis & treatment at the AI@Oxford congress.
University of Oxford has convened AI experts to AI@Oxford, an exciting two-day event, showcasing world-leading research, game changing technologies and the ground-breaking innovative companies created here in Oxford. The sold-out event unites over 500 Oxford academicians, machine learning experts, startups, industry executives, and investors.
Dr. Kadir will speak at the “Big Data Analytics for Health” expert panel, invited by the University of Oxford Big Data Institute , on 18th September from 2.25pm at the Oxford Saïd Business School.

Recent posts

August 24, 2026 / News & Press, Partnerships
SimonMed Launches World’s First Seamlessly Integrated AI Lung Nodule Risk Assessment WorkflowSimonMed is creating the first fully automated AI-powered lung cancer risk assessment workflow deployed at enterprise scale, combining multiple FDA-cleared AI technologies into a...
Read more

August 13, 2026 / News & Press, Partnerships
Coreline Soft and Optellum announce intent to collaborate to advance AI...Proposed collaboration would make Coreline Soft's FDA-cleared lung nodule detection capability available through Optellum's LungOS® platform
Read more

June 15, 2026 / News & Press, Partnerships
Optellum Awarded NIHR Funding for Multi-Site NHS Pilot Study for Accelerated...Optellum announced it has been awarded funding for a competitive programme, Invention for Innovation (i4i), focused on transformative and disruptive innovations to reduce waiting...
Read more
Optellum is trusted by industry & academic leaders




































Certification





Redefining early intervention of lung disease
starting with one of the deadliest, lung cancer
Contact us